Seneca Biopharma Inc fka SNCA

[BesaoT35]

Thanks Stockexpertpro. It is nice to see your thorough post about the valuation here at CUR. If insiders are buying before the most recent reverse split who would want to sell the stock from $8 down to $1.70.

Doing the math we now have 700,000 shares outstanding of CUR stock. The stock price is currently $1.70. That would put the market cap for CUR at $1.2 million or thereabouts.

NSI 189 has been shown to be entirely safe and to grow neurons in the hippocampus. No effectivity has been proven, but in my mind isn’t the potential utility of NSI-189 worth at least $1.2 million? Doesn’t CUR have some other assets that are worth something. We have stem cells and some other intellectual property assets I believe.

What is a fair market cap for CUR just based on what we actually know about NSI-189 and the other assets that we have?

How about selling NSI-189 as a supplement and not making pharmaceutical claims that require FDA approval. It has been proven to be safe to FDA standards.

Thanks again Stockexpertpro.